Literature DB >> 22223267

Definition and risk factors of rapidly declining residual renal function in peritoneal dialysis: an observational study.

Stefan Herget-Rosenthal1, Michael von Ostrowski, Andreas Kribben.   

Abstract

BACKGROUND: It is critical to preserve residual renal function (RRF) in peritoneal dialysis (PD), as RRF is associated with lower morbidity and mortality. There is no uniform definition of RRF, and rapidly declining RRF has rarely been studied and predominately limited to single factor analysis and not corrected for lead-time bias.
METHODS: An observational study in 71 incident PD patients. RRF was defined as urine output (UO) ≥500 ml/day and renal glomerular filtration rate (rGFR) ≥2 ml/min/1.73 m(2), rapid declining RRF as UO <500 ml/day and rGFR <2 ml/min/1.73 m(2) occurring within 6 months which were separately evaluated. Independent risk factors associated with rapid RRF decline were identified while correcting for lead-time bias.
RESULTS: RRF declined rapidly by both definitions in 65% patients 2.5 years after PD start. Both definitions of RRF decline were consistent in 96%. Nephrotoxic drugs, renal transplant failure and absent angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) were independent risk factors associated with rapidly declining RRF defined both by definitions, intravascular radiocontrast additionally for UO decline.
CONCLUSIONS: Most PD patients demonstrated rapid RRF decline, independent of its definition. Both definitions are highly consistent and interchangeable. Nephrotoxic drugs and radiocontrast were identified as risk factors of acute, absent ACEI or ARB, and renal transplant failure of chronic renal injury.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22223267     DOI: 10.1159/000332887

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  12 in total

1.  Comparison of the impact of "fast decline" in residual renal function and "initial anuria" on long-term outcomes in CAPD patients.

Authors:  Yi-Hua Lu; Jyh-Chang Hwang; Ming-Yan Jiang; Charn-Ting Wang
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

2.  Rate of Decline of Residual Kidney Function Before and After the Start of Peritoneal Dialysis.

Authors:  Lian He; Xihui Liu; Zi Li; Zita Abreu; Tushar Malavade; Charmaine E Lok; Joanne M Bargman
Journal:  Perit Dial Int       Date:  2016-04-04       Impact factor: 1.756

3.  Novel predictors of peritonitis-related outcomes in the BRAZPD cohort.

Authors:  Thyago Proença de Moraes; Marcia Olandoski; Jaqueline C T Caramori; Luis C Martin; Natália Fernandes; José Carolino Divino-Filho; Roberto Pecoits-Filho; Pasqual Barretti
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

Review 4.  Advances in Understanding and Management of Residual Renal Function in Patients with Chronic Kidney Disease.

Authors:  Xin Liu; Chunsun Dai
Journal:  Kidney Dis (Basel)       Date:  2016-09-07

Review 5.  Controversies in timing of dialysis initiation and the role of race and demographics.

Authors:  Elani Streja; Susanne B Nicholas; Keith C Norris
Journal:  Semin Dial       Date:  2013-09-19       Impact factor: 3.455

Review 6.  Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.

Authors:  Ling Zhang; Xiaoxi Zeng; Ping Fu; Hong Mei Wu
Journal:  Cochrane Database Syst Rev       Date:  2014-06-23

7.  Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis.

Authors:  Il-Soo Ha; Hui K Yap; Reyner L Munarriz; Pedro H Zambrano; Joseph T Flynn; Ilmay Bilge; Maria Szczepanska; Wai-Ming Lai; Zenaida L Antonio; Ashima Gulati; Nakysa Hooman; Koen van Hoeck; Lina M S Higuita; Enrico Verrina; Günter Klaus; Michel Fischbach; Mohammed A Riyami; Emilja Sahpazova; Anja Sander; Bradley A Warady; Franz Schaefer
Journal:  Kidney Int       Date:  2015-04-15       Impact factor: 10.612

8.  Control of fluid balance guided by body composition monitoring in patients on peritoneal dialysis (COMPASS): study protocol for a randomized controlled trial.

Authors:  Seon Ha Baek; Kook-Hwan Oh; Sejoong Kim; Dong Ki Kim; Kwon-Wook Joo; Yun Kyu Oh; Byoung Geun Han; Jae Hyun Chang; Wookyung Chung; Yon Su Kim; Ki Young Na
Journal:  Trials       Date:  2014-11-06       Impact factor: 2.279

9.  Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients.

Authors:  Satoru Oka; Yoko Obata; Shuntaro Sato; Kenta Torigoe; Miki Sawa; Shinichi Abe; Kumiko Muta; Yuki Ota; Mineaki Kitamura; Satoko Kawasaki; Misaki Hirose; Tadashi Uramatsu; Hiroshi Mukae; Tomoya Nishino
Journal:  Med Sci Monit       Date:  2017-03-26

10.  The Impact of Fluid Overload and Variation on Residual Renal Function in Peritoneal Dialysis Patient.

Authors:  Na Tian; Qunying Guo; Qian Zhou; Peiyi Cao; Lingyao Hong; Menghua Chen; Xiao Yang; Xueqing Yu
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.